Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SYRS

Syros Pharmaceuticals

$10.06

-0.135 (-1.32%)

07:38
08/07/18
08/07
07:38
08/07/18
07:38
Hot Stocks
Syros Pharmaceuticals has sufficient cash, cash equivalents to fund into 2020 »

Based on its current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

SYRS

Syros Pharmaceuticals

$10.06

-0.135 (-1.32%)

07:36
08/07/18
08/07
07:36
08/07/18
07:36
Earnings
Syros Pharmaceuticals reports Q2 EPS (43c), consensus (50c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

SYRS

Syros Pharmaceuticals

$12.74

(0.00%)

04:55
07/18/18
07/18
04:55
07/18/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

Over a quarter ago
SYRS

Syros Pharmaceuticals

$13.12

0.38 (2.98%)

14:29
07/17/18
07/17
14:29
07/17/18
14:29
Recommendations
Syros Pharmaceuticals analyst commentary at Piper Jaffray »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

SYRS

Syros Pharmaceuticals

$12.74

0.39 (3.16%)

08:25
07/17/18
07/17
08:25
07/17/18
08:25
Conference/Events
Syros Pharmaceuticals to hold a key opinion leader meeting »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

SYRS

Syros Pharmaceuticals

$12.74

0.39 (3.16%)

04:55
07/17/18
07/17
04:55
07/17/18
04:55
Conference/Events
Syros Pharmaceuticals to hold a key opinion leader meeting »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

SYRS

Syros Pharmaceuticals

$12.35

(0.00%)

14:08
07/16/18
07/16
14:08
07/16/18
14:08
Conference/Events
Syros Pharmaceuticals to hold a key opinion leader meeting »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SYRS

Syros Pharmaceuticals

$12.35

-0.01 (-0.08%)

06:55
07/16/18
07/16
06:55
07/16/18
06:55
Conference/Events
Syros Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SYRS

Syros Pharmaceuticals

$11.96

(0.00%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SYRS

Syros Pharmaceuticals

$11.96

-0.41 (-3.31%)

05:54
05/22/18
05/22
05:54
05/22/18
05:54
Conference/Events
Syros Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.